BRUNO, ANTONINO
BRUNO, ANTONINO
DIPARTIMENTO DI BIOTECNOLOGIE E SCIENZE DELLA VITA
A Polyphenol-Rich Extract of Olive Mill Wastewater Enhances Cancer Chemotherapy Effects, While Mitigating Cardiac Toxicity
2021-01-01 Albini, A.; Festa, M. M. G.; Ring, N.; Baci, D.; Rehman, M.; Finzi, G.; Sessa, F.; Zacchigna, S.; Bruno, A.; Noonan, D. M.
A potential role of human RNASET2 overexpression in the pathogenesis of Graves’ disease
2023-01-01 Gallo, Daniela; DE VITO, Annarosaria; Roncoroni, Rossella; Bruno, Antonino; Piantanida, ELIANA ANGELA ROSA; Bartalena, Luigi; Tanda, MARIA LAURA PIERA; Mortara, Lorenzo; Acquati, Francesco
A PSA-guided approach for a better diagnosis of prostatic adenocarcinoma based on MALDI profiling and peptide identification
2015-01-01 Fania, C; Sogno, I; Vasso, M; Torretta, E; Leone, R; Bruno, A; Consonni, P; Albini, A; Gelfi, C.
A think tank of TINK/TANKs: Tumor-infiltrating/tumor-associated natural killer cells in tumor progression and angiogenesis
2014-01-01 Bruno, A.; Ferlazzo, G.; Albini, A.; Noonan, D.
Acetyl-L-Carnitine downregulates invasion (CXCR4/CXCL12, MMP-9) and angiogenesis (VEGF, CXCL8) pathways in prostate cancer cells: rationale for prevention and interception strategies
2019-01-01 Baci, D.; Bruno, A.; Cascini, C.; Gallazzi, M.; Mortara, L.; Sessa, F.; Pelosi, G.; Albini, A.; Noonan, D. M.
Acetyl-L-carnitine is an anti-angiogenic agent targeting the VEGFR2 and CXCR4 pathways
2018-01-01 Baci, D.; Bruno, A.; Bassani, B.; Tramacere, M.; Mortara, L.; Albini, A.; Noonan, D. M.
Add-On Effect of Selenium and Vitamin D Combined Supplementation in Early Control of Graves’ Disease Hyperthyroidism During Methimazole Treatment
2022-01-01 Gallo, Daniela; Mortara, Lorenzo; Veronesi, Giovanni; Cattaneo, Simona AM; Genoni, Angelo; Gallazzi, Matteo; Peruzzo, Carlo; Lasalvia, Paolo; Moretto, Paola; Bruno, Antonino; Passi, Alberto; Pini, Andrea; Nauti, Andrea; Lavizzari, Maria Antonietta; Marinò, Michele; Lanzolla, Giulia; Tanda, Maria Laura; Bartalena, Luigi; Piantanida, Eliana
Adipose mesenchymal stem cell-derived soluble factors, produced under hypoxic condition, efficiently support in vivo angiogenesis
2023-01-01 Barone, Ludovica; Palano, Maria Teresa; Gallazzi, Matteo; Cucchiara, Martina; Rossi, Federica; Borgese, Marina; Raspanti, Mario; Zecca, Piero Antonio; Mortara, Lorenzo; Papait, Roberto; Bernardini, Giovanni; Valdatta, Luigi; Bruno, Antonino; Gornati, Rosalba
An Olive Oil Mill Wastewater Extract Improves Chemotherapeutic Activity Against Breast Cancer Cells While Protecting From Cardiotoxicity
2022-01-01 Benedetto, Nadia; Calabrone, Luana; Gutmańska, Karolina; Macrì, Nicoletta; Cerrito, Maria Grazia; Ricotta, Riccardo; Pelosi, Giuseppe; Bruno, Antonino; Noonan, Douglas M; Albini, Adriana
Angiogenin and the MMP9-TIMP2 axis are up-regulated in proangiogenic, decidual NK-like cells from patients with colorectal cancer
2018-01-01 Bruno, A.; Bassani, B.; D’Urso, D. G.; Pitaku, Ilvana; Cassinotti, E.; Pelosi, Giuliano; Boni, L.; Dominioni, L.; Noonan, D. M.; Mortara, L.; Albini, A.
Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy
2018-01-01 Mortara, L.; Balza, E.; Bruno, A.; Poggi, A.; Orecchia, P.; Carnemolla, B.
Biomarkers of cancer angioprevention for clinical studies
2015-01-01 Albini, Adriana; Bertolini, Francesco; Bassani, Barbara; Bruno, Antonino; Gallo, Cristina; Caraffi, Stefano Giuseppe; Maramotti, Sally; Noonan, Douglas
Cancer stem cells and the tumor microenvironment: Interplay in tumor heterogeneity
2015-01-01 Albini, Adriana; Bruno, Antonino; Gallo, Cristina; Pajardi, Giorgio; Noonan, Douglas; Dallaglio, Katiuscia
Cardiovascular active peptides of marine origin with ACE inhibitory activities: Potential role as anti-hypertensive drugs and in prevention of SARSCoV-2 infection
2020-01-01 Festa, M.; Sansone, C.; Brunet, C.; Crocetta, F.; Di Paola, L.; Lombardo, M.; Bruno, A.; Noonan, D. M.; Albini, A.
Characterization of circulating and tumor infiltrating Natural Killer cells in patients with pancreatic ductal adenocarcinoma: polarization state and effects of TGFβRI blockade
2022-01-01 Teresa Palano, Maria; Cucchiara, Martina; Gallazzi, Matteo; Persichitti, Perla; Ricotta, Riccardo; Taraboletti, Giulia; Belotti, Dorina; Resovi, Andrea; Bruno, Antonino
Circulating and tumor infiltrating natural killer cells in renal cancer patients express the CD9 and CD49a decidual markers and have increased activation of STAT3
2023-01-01 Cucchiara, Martina; Gallazzi, Matteo; Coco, Grace; Bombelli, RAFFAELLA MARIA; Olmeo, Francesca; Franzi, Francesca; Famoso, Graziana; Sessa, Fausto; Capogrosso, Paolo; Dehò, Federico; Bruno, Antonino; Mortara, Lorenzo
Circulating and tumour infiltrating NK cells acquire the decidual-like CD9+CD49a+ phenotype in pancreatic ductal adenocarcinoma: reversion by anti-fibrotic treatments
2022-01-01 Teresa Palano, Maria; Cucchiara, Martina; Gallazzi, Matteo; Persichitti, Perla; Ricotta, Riccardo; Mortara, Lorenzo; Taraboletti, Giulia; Belotti, Dorina; Resovi, Andrea; Bruno, Antonino
Circulating Natural Killer cells in patients with symptomatic atherosclerosis acquire the CD9 + CD49a pro-inflammatory phenotype and support M1-like macrophage polarization
2022-01-01 Cucchiara, Martina; Gallazzi, Matteo; Carlini, Valentina; Martelli, Massimiliano; Albini, Adriana; Bruno, Antonino; Noonan, Douglas
Co-targeting triple-negative breast cancer cells and endothelial cells by metronomic chemotherapy inhibits cell regrowth and migration via downregulation of the FAK/VEGFR2/VEGF axis and autophagy/apoptosis activation
2022-01-01 Scagliotti, Arianna; Capizzi, Laura; Cazzaniga, Marina Elena; Ilari, Alice; De Giorgi, Marco; Cordani, Nicoletta; Gallazzi, Matteo; Bruno, Antonino; Pelosi, Giuseppe; Albini, Adriana; Lavitrano, Marialuisa; Grassilli, Emanuela; Cerrito, Maria Grazia
Contribution to tumor angiogenesis from innate immune cells within the tumor microenvironment: Implications for immunotherapy
2018-01-01 Albini, A.; Bruno, A.; Noonan, D. M.; Mortara, L.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A Polyphenol-Rich Extract of Olive Mill Wastewater Enhances Cancer Chemotherapy Effects, While Mitigating Cardiac Toxicity | 1-gen-2021 | Albini, A.; Festa, M. M. G.; Ring, N.; Baci, D.; Rehman, M.; Finzi, G.; Sessa, F.; Zacchigna, S.; Bruno, A.; Noonan, D. M. | |
| A potential role of human RNASET2 overexpression in the pathogenesis of Graves’ disease | 1-gen-2023 | Gallo, Daniela; DE VITO, Annarosaria; Roncoroni, Rossella; Bruno, Antonino; Piantanida, ELIANA ANGELA ROSA; Bartalena, Luigi; Tanda, MARIA LAURA PIERA; Mortara, Lorenzo; Acquati, Francesco | |
| A PSA-guided approach for a better diagnosis of prostatic adenocarcinoma based on MALDI profiling and peptide identification | 1-gen-2015 | Fania, C; Sogno, I; Vasso, M; Torretta, E; Leone, R; Bruno, A; Consonni, P; Albini, A; Gelfi, C. | |
| A think tank of TINK/TANKs: Tumor-infiltrating/tumor-associated natural killer cells in tumor progression and angiogenesis | 1-gen-2014 | Bruno, A.; Ferlazzo, G.; Albini, A.; Noonan, D. | |
| Acetyl-L-Carnitine downregulates invasion (CXCR4/CXCL12, MMP-9) and angiogenesis (VEGF, CXCL8) pathways in prostate cancer cells: rationale for prevention and interception strategies | 1-gen-2019 | Baci, D.; Bruno, A.; Cascini, C.; Gallazzi, M.; Mortara, L.; Sessa, F.; Pelosi, G.; Albini, A.; Noonan, D. M. | |
| Acetyl-L-carnitine is an anti-angiogenic agent targeting the VEGFR2 and CXCR4 pathways | 1-gen-2018 | Baci, D.; Bruno, A.; Bassani, B.; Tramacere, M.; Mortara, L.; Albini, A.; Noonan, D. M. | |
| Add-On Effect of Selenium and Vitamin D Combined Supplementation in Early Control of Graves’ Disease Hyperthyroidism During Methimazole Treatment | 1-gen-2022 | Gallo, Daniela; Mortara, Lorenzo; Veronesi, Giovanni; Cattaneo, Simona AM; Genoni, Angelo; Gallazzi, Matteo; Peruzzo, Carlo; Lasalvia, Paolo; Moretto, Paola; Bruno, Antonino; Passi, Alberto; Pini, Andrea; Nauti, Andrea; Lavizzari, Maria Antonietta; Marinò, Michele; Lanzolla, Giulia; Tanda, Maria Laura; Bartalena, Luigi; Piantanida, Eliana | |
| Adipose mesenchymal stem cell-derived soluble factors, produced under hypoxic condition, efficiently support in vivo angiogenesis | 1-gen-2023 | Barone, Ludovica; Palano, Maria Teresa; Gallazzi, Matteo; Cucchiara, Martina; Rossi, Federica; Borgese, Marina; Raspanti, Mario; Zecca, Piero Antonio; Mortara, Lorenzo; Papait, Roberto; Bernardini, Giovanni; Valdatta, Luigi; Bruno, Antonino; Gornati, Rosalba | |
| An Olive Oil Mill Wastewater Extract Improves Chemotherapeutic Activity Against Breast Cancer Cells While Protecting From Cardiotoxicity | 1-gen-2022 | Benedetto, Nadia; Calabrone, Luana; Gutmańska, Karolina; Macrì, Nicoletta; Cerrito, Maria Grazia; Ricotta, Riccardo; Pelosi, Giuseppe; Bruno, Antonino; Noonan, Douglas M; Albini, Adriana | |
| Angiogenin and the MMP9-TIMP2 axis are up-regulated in proangiogenic, decidual NK-like cells from patients with colorectal cancer | 1-gen-2018 | Bruno, A.; Bassani, B.; D’Urso, D. G.; Pitaku, Ilvana; Cassinotti, E.; Pelosi, Giuliano; Boni, L.; Dominioni, L.; Noonan, D. M.; Mortara, L.; Albini, A. | |
| Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy | 1-gen-2018 | Mortara, L.; Balza, E.; Bruno, A.; Poggi, A.; Orecchia, P.; Carnemolla, B. | |
| Biomarkers of cancer angioprevention for clinical studies | 1-gen-2015 | Albini, Adriana; Bertolini, Francesco; Bassani, Barbara; Bruno, Antonino; Gallo, Cristina; Caraffi, Stefano Giuseppe; Maramotti, Sally; Noonan, Douglas | |
| Cancer stem cells and the tumor microenvironment: Interplay in tumor heterogeneity | 1-gen-2015 | Albini, Adriana; Bruno, Antonino; Gallo, Cristina; Pajardi, Giorgio; Noonan, Douglas; Dallaglio, Katiuscia | |
| Cardiovascular active peptides of marine origin with ACE inhibitory activities: Potential role as anti-hypertensive drugs and in prevention of SARSCoV-2 infection | 1-gen-2020 | Festa, M.; Sansone, C.; Brunet, C.; Crocetta, F.; Di Paola, L.; Lombardo, M.; Bruno, A.; Noonan, D. M.; Albini, A. | |
| Characterization of circulating and tumor infiltrating Natural Killer cells in patients with pancreatic ductal adenocarcinoma: polarization state and effects of TGFβRI blockade | 1-gen-2022 | Teresa Palano, Maria; Cucchiara, Martina; Gallazzi, Matteo; Persichitti, Perla; Ricotta, Riccardo; Taraboletti, Giulia; Belotti, Dorina; Resovi, Andrea; Bruno, Antonino | |
| Circulating and tumor infiltrating natural killer cells in renal cancer patients express the CD9 and CD49a decidual markers and have increased activation of STAT3 | 1-gen-2023 | Cucchiara, Martina; Gallazzi, Matteo; Coco, Grace; Bombelli, RAFFAELLA MARIA; Olmeo, Francesca; Franzi, Francesca; Famoso, Graziana; Sessa, Fausto; Capogrosso, Paolo; Dehò, Federico; Bruno, Antonino; Mortara, Lorenzo | |
| Circulating and tumour infiltrating NK cells acquire the decidual-like CD9+CD49a+ phenotype in pancreatic ductal adenocarcinoma: reversion by anti-fibrotic treatments | 1-gen-2022 | Teresa Palano, Maria; Cucchiara, Martina; Gallazzi, Matteo; Persichitti, Perla; Ricotta, Riccardo; Mortara, Lorenzo; Taraboletti, Giulia; Belotti, Dorina; Resovi, Andrea; Bruno, Antonino | |
| Circulating Natural Killer cells in patients with symptomatic atherosclerosis acquire the CD9 + CD49a pro-inflammatory phenotype and support M1-like macrophage polarization | 1-gen-2022 | Cucchiara, Martina; Gallazzi, Matteo; Carlini, Valentina; Martelli, Massimiliano; Albini, Adriana; Bruno, Antonino; Noonan, Douglas | |
| Co-targeting triple-negative breast cancer cells and endothelial cells by metronomic chemotherapy inhibits cell regrowth and migration via downregulation of the FAK/VEGFR2/VEGF axis and autophagy/apoptosis activation | 1-gen-2022 | Scagliotti, Arianna; Capizzi, Laura; Cazzaniga, Marina Elena; Ilari, Alice; De Giorgi, Marco; Cordani, Nicoletta; Gallazzi, Matteo; Bruno, Antonino; Pelosi, Giuseppe; Albini, Adriana; Lavitrano, Marialuisa; Grassilli, Emanuela; Cerrito, Maria Grazia | |
| Contribution to tumor angiogenesis from innate immune cells within the tumor microenvironment: Implications for immunotherapy | 1-gen-2018 | Albini, A.; Bruno, A.; Noonan, D. M.; Mortara, L. |